Wen D - Search Results

1

Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer.

Ma B, Liao T, Wen D, Dong C, Zhou L, Yang S, Wang Y, Ji Q. Ma B, et al. Among authors: wen d. Sci Rep. 2016 Nov 11;6:36973. doi: 10.1038/srep36973. Sci Rep. 2016. PMID: 27833134 Free PMC article.

2

Screening and Identifying a Novel ssDNA Aptamer against Alpha-fetoprotein Using CE-SELEX.

Dong L, Tan Q, Ye W, Liu D, Chen H, Hu H, Wen D, Liu Y, Cao Y, Kang J, Fan J, Guo W, Wu W. Dong L, et al. Among authors: wen d. Sci Rep. 2015 Oct 26;5:15552. doi: 10.1038/srep15552. Sci Rep. 2015. PMID: 26497223 Free PMC article.

3

Tumor size interpretation for predicting cervical lymph node metastasis using a differentiated thyroid cancer risk model.

Shi RL, Qu N, Yang SW, Ma B, Lu ZW, Wen D, Sun GH, Wang Y, Ji QH. Shi RL, et al. Among authors: wen d. Onco Targets Ther. 2016 Aug 12;9:5015-22. doi: 10.2147/OTT.S107187. eCollection 2016. Onco Targets Ther. 2016. PMID: 27574443 Free PMC article.

4

Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis.

Qu N, Shi RL, Lu ZW, Liao T, Wen D, Sun GH, Li DS, Ji QH. Qu N, et al. Among authors: wen d. Oncotarget. 2016 Oct 4;7(40):65937-65945. doi: 10.18632/oncotarget.11725. Oncotarget. 2016. PMID: 27588396 Free PMC article.

5

Yes-associated protein 1 promotes papillary thyroid cancer cell proliferation by activating the ERK/MAPK signaling pathway.

Liao T, Wen D, Ma B, Hu JQ, Qu N, Shi RL, Liu L, Guan Q, Li DS, Ji QH. Liao T, et al. Among authors: wen d. Oncotarget. 2017 Feb 14;8(7):11719-11728. doi: 10.18632/oncotarget.14319. Oncotarget. 2017. PMID: 28036290 Free PMC article.

6

Corrigendum: Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer.

Ma B, Liao T, Wen D, Dong C, Zhou L, Yang S, Wang Y, Ji Q. Ma B, et al. Among authors: wen d. Sci Rep. 2017 Feb 9;7:42321. doi: 10.1038/srep42321. Sci Rep. 2017. PMID: 28181550 Free PMC article. No abstract available.

7

Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation.

Cao YM, Gu J, Zhang YS, Wei WJ, Qu N, Wen D, Liao T, Shi RL, Zhang L, Ji QH, Wang Y, Sun GH, Zhao YX, Wang YJ, Yu J, Zhu YX. Cao YM, et al. Among authors: wen d. Oncol Rep. 2018 Jan;39(1):338-348. doi: 10.3892/or.2017.6058. Epub 2017 Oct 25. Oncol Rep. 2018. PMID: 29115628

8

The Positive Lymph Node Number and Postoperative N-Staging Used to Estimate Survival in Patients with Differentiated Thyroid Cancer: Results from the Surveillance, Epidemiology, and End Results Dataset (1988-2008).

Wei WJ, Lu ZW, Wen D, Liao T, Li DS, Wang Y, Zhu YX, Wang ZY, Wu Y, Wang YL, Ji QH. Wei WJ, et al. Among authors: wen d. World J Surg. 2018 Jun;42(6):1762-1771. doi: 10.1007/s00268-017-4343-6. World J Surg. 2018. PMID: 29185020

9

Mediastinal Lymph Node Metastases in Thyroid Cancer: Characteristics, Predictive Factors, and Prognosis.

Zhang TT, Qu N, Hu JQ, Shi RL, Wen D, Sun GH, Ji QH. Zhang TT, et al. Among authors: wen d. Int J Endocrinol. 2017;2017:1868165. doi: 10.1155/2017/1868165. Epub 2017 Nov 12. Int J Endocrinol. 2017. PMID: 29259627 Free PMC article.

10

Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy.

Wen D, Liao T, Ma B, Qu N, Shi RL, Lu ZW, Wang YL, Wei WJ, Ji QH. Wen D, et al. Cancer Med. 2018 Feb;7(2):285-296. doi: 10.1002/cam4.1272. Epub 2018 Jan 17. Cancer Med. 2018. PMID: 29341469 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,299 results

Search Page

Filters